陇神戎发：11月4日召开董事会会议

Company Overview - Longshen Rongfa (SZ 300534) held its 24th meeting of the 5th Board of Directors on November 4, 2025, to discuss the adjustment of the special committee members [1] - As of the report date, Longshen Rongfa has a market capitalization of 3.1 billion yuan [1] Revenue Composition - For the first half of 2025, Longshen Rongfa's revenue composition is as follows: - Pharmaceutical sales accounted for 86.53% - Medical device sales accounted for 6.69% - Logistics and distribution accounted for 4.48% - Rental income accounted for 0.76% - Consulting services accounted for 0.7% [1] Industry Insights - A significant increase in overseas orders by 246% has been reported, covering over 50 countries and regions, indicating a booming industry [1] - Entrepreneurs have raised concerns about some companies selling products at a loss, warning of potential vicious competition expanding overseas [1]